A clinical study to compare the the sedative drug combination dexmedetomidine plus ketamine and midazolam plus ketamine on patients undergoing short surgical procedures.
Phase 4
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecifiedHealth Condition 2: K929- Disease of digestive system, unspecifiedHealth Condition 3: N359- Urethral stricture, unspecified
- Registration Number
- CTRI/2021/08/035523
- Lead Sponsor
- Dr Seethal Ann Sunny
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Consent to participate in study
ASA physical Grade 1 and 2
Patients undergoing short surgical procedures
Exclusion Criteria
Patients refusal.
Pregnancy and lactating women.
History of any significant pulmonary, cardiovascular, neurological, hepatoreanal or metabolic disease.
chronic use or addiction to opiates or sedatives.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method we expect that dexmedetomidine plus ketamine will provide adequate depth of anaesthesia and more stable hemodynamic variables.Timepoint: 20 weeks
- Secondary Outcome Measures
Name Time Method We expect dexmedetomidine plus ketamine to provide less incidence of postoperative complicationsTimepoint: 20 weeks